Study tests if teaching doctors and patients boosts lung cancer screening
NCT ID NCT05679349
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether providing education and decision counseling to both healthcare providers and patients can increase the number of people who get screened for lung cancer. The trial involves 822 participants who have a history of smoking. Researchers will track how many complete their initial lung cancer screening and follow-up annual screenings.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that simple education and counseling can significantly boost lung cancer screening rates, catching cancer earlier.
- What could go wrong
- This is an early-stage behavioral study, not testing a new drug or device. Results may not apply to all clinics or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 822 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2024
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 77 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * PRACTICE LEVEL: * Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems * Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports * Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate * PATIENT LEVEL: * Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days * 50 to 77 years of age * Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment) * Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment) * Able to communicate in English or Spanish (determined at baseline eligibility assessment) Exclusion Criteria: * PATIENT OUTREACH: * Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows * G0297 - LDCT screening * 71250 - CT w/o contrast * 71260 - CT w/ contrast * 71270 - CT with and w/o contrast * 71275 - CT angiography chest * 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh * 78816 - PET CT whole body * Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment) * Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment) * Dementia (diagnosis codes F03.90 or F03.91) in EHR
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can new tracers make many cancers light up on scans?
- Can tumor avatars reveal why cancer hits minorities harder?
- App-based therapy aims to break teen vaping addiction
- Can the right message steer young adults away from nicotine pouches?
- New PET tracer could spot cancers that standard scans overlook
- Can a conversation aid empower lung cancer patients?